Σάββατο 10 Μαρτίου 2018

Assessing Key Stakeholders’ Knowledge, Needs, and Preferences for Head and Neck Cancer Survivorship Care Plans

Abstract

Cancer survivorship care plans (SCPs) are endorsed to support quality care for cancer survivors, but uptake is slow. We assessed knowledge, needs, and preferences for SCP content and delivery from a wide variety of stakeholders. We focused SCP content for head and neck cancer as it is a disease prone to long-term side effects requiring management from multiple providers. We conducted telephone-based, qualitative interviews. We purposively sampled head and neck cancer survivors (n = 4), primary care physicians in the community (n = 5), and providers affiliated with a large academic medical center (n = 5) who treat head and neck cancer, cancer specialists (n = 6), and nurse practitioners/supportive care staff (n = 5). Interviews were recorded, transcribed, and analyzed using direct content analysis. Few participants reported personal experience with SCPs, but most supported the concept. Several key themes emerged: (1) perceived ambiguity regarding roles and responsibilities for SCPs, (2) a need to tailor the content and language based on the intended recipient, (3) documentation process should be as automated and streamlined as possible, (4) concerns about using the SCP to coordinate with outside providers, and (5) that SCPs would have added value as a "living document." We also report SCP-related issues that are unique to serving patients diagnosed with head and neck cancer. Effort is needed to tailor SCPs for different recipients and optimize their potential for successful implementation, impact on care outcomes, and sustainability. Many cancer survivors may not receive a SCP as part of routine care. Survivors could engage their health care team by requesting a SCP.



from Cancer via ola Kala on Inoreader http://ift.tt/2IeJVlo
via IFTTT

Assessing Key Stakeholders’ Knowledge, Needs, and Preferences for Head and Neck Cancer Survivorship Care Plans

Abstract

Cancer survivorship care plans (SCPs) are endorsed to support quality care for cancer survivors, but uptake is slow. We assessed knowledge, needs, and preferences for SCP content and delivery from a wide variety of stakeholders. We focused SCP content for head and neck cancer as it is a disease prone to long-term side effects requiring management from multiple providers. We conducted telephone-based, qualitative interviews. We purposively sampled head and neck cancer survivors (n = 4), primary care physicians in the community (n = 5), and providers affiliated with a large academic medical center (n = 5) who treat head and neck cancer, cancer specialists (n = 6), and nurse practitioners/supportive care staff (n = 5). Interviews were recorded, transcribed, and analyzed using direct content analysis. Few participants reported personal experience with SCPs, but most supported the concept. Several key themes emerged: (1) perceived ambiguity regarding roles and responsibilities for SCPs, (2) a need to tailor the content and language based on the intended recipient, (3) documentation process should be as automated and streamlined as possible, (4) concerns about using the SCP to coordinate with outside providers, and (5) that SCPs would have added value as a "living document." We also report SCP-related issues that are unique to serving patients diagnosed with head and neck cancer. Effort is needed to tailor SCPs for different recipients and optimize their potential for successful implementation, impact on care outcomes, and sustainability. Many cancer survivors may not receive a SCP as part of routine care. Survivors could engage their health care team by requesting a SCP.



http://ift.tt/2IeJVlo

A Case of Nongerminomatous Germ Cell Tumor of the Pineal Region: Risks and Advantages of Biopsy by Endoscopic Approach

A 21-year-old male was admitted to our department with headache and drowsiness. CT scan and MRI revealed acute obstructive hydrocephalus caused by a pineal region mass. The serum and CSF levels of beta-human chorionic gonadotropin (beta-hCG) were 215 IU/L and 447 IU/L, respectively, while levels of alpha-fetoprotein (AFP) were normal. A germ cell tumor (GCT) was suspected, and the patient underwent endoscopic third ventriculostomy (ETV) with biopsy. After four days from surgery, the tumor bled with mass expansion and ETV stoma occlusion; thus, a ventriculoperitoneal shunt was positioned. After ten months, the tumor metastasized to the thorax and abdomen with progression of intracerebral tumor mass. Despite the aggressive nature of this tumor, ETV remains a valid approach for a pineal region mass, but in case of GCT, the risk of bleeding should be taken into account, during and after the surgical procedure.

http://ift.tt/2txSuV0

Reducing X-Ray imaging for proton postmastectomy chest-wall patients

alertIcon.gif

Publication date: Available online 10 March 2018
Source:Practical Radiation Oncology
Author(s): Estelle Batin, Nicolas Depauw, Rachel B. Jimenez, Shannon MacDonald, Hsiao-Ming Lu




http://ift.tt/2oWTZrm

Renal Cell Carcinoma Brain Metastasis with Pseudoprogression and Radiation Necrosis on Nivolumab after previous treatment with Stereotactic Radiosurgery: an Illustrative Case Report and Review of the Literature

alertIcon.gif

Publication date: Available online 10 March 2018
Source:Practical Radiation Oncology
Author(s): Gary D. Lewis, Eric Jonasch, Amishi Shah, Gregory N. Fuller, Andrew M. Farach, E. Brian Butler, Bin S. Teh




http://ift.tt/2DiNC5I

Reducing X-Ray imaging for proton postmastectomy chest-wall patients

alertIcon.gif

Publication date: Available online 10 March 2018
Source:Practical Radiation Oncology
Author(s): Estelle Batin, Nicolas Depauw, Rachel B. Jimenez, Shannon MacDonald, Hsiao-Ming Lu




from Cancer via ola Kala on Inoreader http://ift.tt/2oWTZrm
via IFTTT

Renal Cell Carcinoma Brain Metastasis with Pseudoprogression and Radiation Necrosis on Nivolumab after previous treatment with Stereotactic Radiosurgery: an Illustrative Case Report and Review of the Literature

alertIcon.gif

Publication date: Available online 10 March 2018
Source:Practical Radiation Oncology
Author(s): Gary D. Lewis, Eric Jonasch, Amishi Shah, Gregory N. Fuller, Andrew M. Farach, E. Brian Butler, Bin S. Teh




from Cancer via ola Kala on Inoreader http://ift.tt/2DiNC5I
via IFTTT